Ashraf El Attar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashraf El Attar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Ali Shehata
Pediatric Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt
2 shared publications - Wael Abosena
Tanta University, Tanta, Egypt
2 shared publications - Ahmed Elhaddad
Tanta University, Tanta, Egypt
1 shared publication - Ayman El-Dorf
Tanta University, Tanta, Egypt
1 shared publication - Mohamed Ahmed Elghazeery
Pediatric Surgery Unit, Faculty of Medicine, Tanta University, Tanta, Egypt
1 shared publication - Mohammad Gharieb Khirallah
Department of General Surgery, Pediatric Surgery Unit, Faculty of Medicine, Tanta University, Tanta University Hospitals, Tanta, Egypt
1 shared publication
Latest Publications
- Open Access
- 9 July 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (9) , 1-12
Female Fertility Outcome Following Bariatric Surgery: Five-Year Follow Up
Background: To evaluate fertility, weight loss, improvement in obesity related comorbidities, and pregnancy outcomes over five years following metabolic bariatric surgery (laparoscopic sleeve gastrectomy [LSG] and laparoscopic Roux-en-Y gastric bypass [LRYGB]) in morbidly obese premenopausal women with infertility or planning pregnancy. Methods: This retrospective cohort study included 79 adult females with morbid obesity who underwent LSG (n = 38) or LRYGB (n = 41). After 5 years of follow up: we evaluated percentage excess weight loss (%EWL), comorbidities improvement, postoperative complications or mortality, and fertility outcomes. Fertility outcomes were assessed in three subgroups: primary infertility (n = 21), secondary infertility (n = 8), and pre-marriage patients (n = 50). Results: Both procedures achieved sustained weight loss (5-year %EWL: LSG 63.1 ± 1.5%, LRYGB 65.2 ± 8.1%; p = 0.16). Conception rates were high across all subgroups (primary infertility: LSG 80%, LRYGB 72.7%; secondary infertility: 100% both; pre-marriage: LSG 100%, LRYGB 92.3%). LRYGB demonstrated superior remission of type 2 diabetes (100% vs 66.7%, p = 0.038) and GERD (85.7% vs 40%, p = 0.015). Pregnancy-related complications, including gestational diabetes and hypertension, were minimal and resolved postpartum. No neonatal anomalies were reported. Cesarean section rates were high in both groups (63.1%–65.8%), likely reflecting cultural or provider preferences rather than surgical indication. Conclusions: Both LSG and LRYGB are effective and safe in improving fertility, achieving significant weight loss, and supporting favorable pregnancy outcomes in morbidly obese women. LRYGB may be preferred for patients with metabolic comorbidities, especially type 2 diabetes and GERD. Metabolic Bariatric surgery should be considered early in reproductive planning for selected patients.
- 9 July 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (9) , 1-12
Open AccessFemale Fertility Outcome Following Bariatric Surgery: Five-Year Follow Up
Background: To evaluate fertility, weight loss, improvement in obesity related comorbidities, and pregnancy outcomes over five years following metabolic bariatric surgery (laparoscopic sleeve gastrectomy [LSG] and laparoscopic Roux-en-Y gastric bypass [LRYGB]) in morbidly obese premenopausal women with infertility or planning pregnancy. Methods: This retrospective cohort study included 79 adult females with morbid obesity who underwent LSG (n = 38) or LRYGB (n = 41). After 5 years of follow up: we evaluated percentage excess weight loss (%EWL), comorbidities improvement, postoperative complications or mortality, and fertility outcomes. Fertility outcomes were assessed in three subgroups: primary infertility (n = 21), secondary infertility (n = 8), and pre-marriage patients (n = 50). Results: Both procedures achieved sustained weight loss (5-year %EWL: LSG 63.1 ± 1.5%, LRYGB 65.2 ± 8.1%; p = 0.16). Conception rates were high across all subgroups (primary infertility: LSG 80%, LRYGB 72.7%; secondary infertility: 100% both; pre-marriage: LSG 100%, LRYGB 92.3%). LRYGB demonstrated superior remission of type 2 diabetes (100% vs 66.7%, p = 0.038) and GERD (85.7% vs 40%, p = 0.015). Pregnancy-related complications, including gestational diabetes and hypertension, were minimal and resolved postpartum. No neonatal anomalies were reported. Cesarean section rates were high in both groups (63.1%–65.8%), likely reflecting cultural or provider preferences rather than surgical indication. Conclusions: Both LSG and LRYGB are effective and safe in improving fertility, achieving significant weight loss, and supporting favorable pregnancy outcomes in morbidly obese women. LRYGB may be preferred for patients with metabolic comorbidities, especially type 2 diabetes and GERD. Metabolic Bariatric surgery should be considered early in reproductive planning for selected patients.
- Open Access
- 16 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (7) , 2680-2688
Seven Years Follow-Up after Sleeve Gastrectomy in Adolescents
Background: Adolescent obesity is a growing global health challenge, often accompanied by serious comorbidities. This study evaluates the long-term outcomes of laparoscopic sleeve gastrectomy (LSG) in adolescents, focusing on weight loss, comorbidity resolution, and post-surgical complications over a seven-year period. Materials and Methods: A retrospective analysis was conducted on 63 adolescents (mean age: 15.4 ± 2.39 years) at Tanta university hospitals, Egypt, who underwent LSG between 2014 and 2015. Outcomes assessed included body mass index (BMI), percent total weight loss (%TWL), percent excess weight loss (%EWL), excess BMI loss (%EBMIL), comorbidity resolution, and gastric volumetry at 1, 3, 5, and 7 years postoperatively. Results: Mean BMI declined from 48.1 ± 10.55 to 29.3 ± 8.53 kg/m2, with %TWL peaking at 32.9% at year 3 and moderating to 29.1% by year 7. Significant reductions were observed in diabetes (34.9% to 11.1%), hypertension (60.3% to 12.7%), obstructive sleep apnea (39.7% to 6.4%), GERD (25.4% to 4.8%), and dyslipidemia (42.9% to 3.2%) (all p < 0.05). The overall complication rate was low (7.9%), and 14.3% required revisional surgery. Among married participants, 76.9% achieved successful pregnancies. Conclusions: LSG is a safe and effective long-term intervention for adolescents with severe obesity, yielding sustained weight loss and significant comorbidity remission, with favorable fertility outcomes among married patients. Despite modest weight regain and a limited rate of reoperations, outcomes support LSG as a durable option. Long-term follow-up and individualized care remain essential.
- 16 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (7) , 2680-2688
Open AccessSeven Years Follow-Up after Sleeve Gastrectomy in Adolescents
Background: Adolescent obesity is a growing global health challenge, often accompanied by serious comorbidities. This study evaluates the long-term outcomes of laparoscopic sleeve gastrectomy (LSG) in adolescents, focusing on weight loss, comorbidity resolution, and post-surgical complications over a seven-year period. Materials and Methods: A retrospective analysis was conducted on 63 adolescents (mean age: 15.4 ± 2.39 years) at Tanta university hospitals, Egypt, who underwent LSG between 2014 and 2015. Outcomes assessed included body mass index (BMI), percent total weight loss (%TWL), percent excess weight loss (%EWL), excess BMI loss (%EBMIL), comorbidity resolution, and gastric volumetry at 1, 3, 5, and 7 years postoperatively. Results: Mean BMI declined from 48.1 ± 10.55 to 29.3 ± 8.53 kg/m2, with %TWL peaking at 32.9% at year 3 and moderating to 29.1% by year 7. Significant reductions were observed in diabetes (34.9% to 11.1%), hypertension (60.3% to 12.7%), obstructive sleep apnea (39.7% to 6.4%), GERD (25.4% to 4.8%), and dyslipidemia (42.9% to 3.2%) (all p < 0.05). The overall complication rate was low (7.9%), and 14.3% required revisional surgery. Among married participants, 76.9% achieved successful pregnancies. Conclusions: LSG is a safe and effective long-term intervention for adolescents with severe obesity, yielding sustained weight loss and significant comorbidity remission, with favorable fertility outcomes among married patients. Despite modest weight regain and a limited rate of reoperations, outcomes support LSG as a durable option. Long-term follow-up and individualized care remain essential.